Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.15p +0.85% 17.75p 17.50p 18.00p 17.75p 17.60p 17.60p 2,208,318 10:30:43
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 68.3 -6.9 -1.3 - 114.33

Allergy Therapeutics Share Discussion Threads

Showing 3601 to 3624 of 3625 messages
Chat Pages: 145  144  143  142  141  140  139  138  137  136  135  134  Older
DateSubjectAuthorDiscuss
23/10/2018
18:46
Hard to believe this is just about market pullback. If a big investor like Blackrock is selling, and no news after a huge study such as the birch one, they must be in troubled waters. If the study had successful results they would have published them to raise stock value.
ptturner
23/10/2018
18:32
How can anyone think this share is cheap? It's a massive cash absorption machine, the deficit on the P&L is over £120m.
arthur_lame_stocks
23/10/2018
16:21
Current AGY website states these companies having major holdings: CFR International SPA & Associated Holding 240,584,571 37.82% Southern Fox Investments 127,238,783 22.69% Odey Assest Management 43,747,523 6.88% Black Rock Investment Management 30,368,413 4.79% Invesco 28,618,373 4.50& Black Rock still have someway to go if current % accurate & they want to offload everything. Annoying that they are selling at a time of little news and poor liquidity which knackers the share price. Can't have made them much profit.
mobox1
23/10/2018
15:36
Now that we all know that it was Blackrock that has been selling all that remains to know are a) Why? b) Is that it? Mmmmm
jimmyloser
23/10/2018
12:03
I should think so! Stupid price. This is AGY.
jimmyloser
23/10/2018
11:55
Topped up this morning...feels like the overhang has cleared. Good price anyway.
mobox1
22/10/2018
22:36
Mr Market suffers from a bi-polar disorder - he is in a risk-off mood at the moment - nothing underlying needs to have changed.
maddox
22/10/2018
09:41
Overhang eaten into this morning 17.6p are buys
jimmyloser
18/10/2018
19:30
Lots of trials = lots of cash needed to pay for them.
elsa7878
18/10/2018
13:16
Hard to be a buyer when you can buy in size at the bid price! (as was the case yesterday - not tried today) Not often that you see that. Clearly a very large seller looking to exit and not getting much interest.
elsa7878
18/10/2018
08:34
The pullback is definitely more than a simple market correction. I do not know what bad news they could be sitting on as the critical phase III trials do not start till next year. There appears to be someone offloading a large amount of shares but the reason is a mystery. Would be nice to see some buying from the BOD to restore confidence.
mobox1
18/10/2018
08:28
fwiw I believe and have been buying this morning!
jimmyloser
18/10/2018
08:08
The drop appears more than would be expected from the recent market pull back. Must admit I'm worried they are sat on bad news. The sharesmag video does not exactly convey confidence in the outcome of clinical trials with immunological end-points!
audigger
17/10/2018
21:00
Yet another massive losing dog for my back drawer and forget or write off category. Trouble is I need a bigger cupboard for all of em now!
jpuff
17/10/2018
15:46
I do hope that this is not too soon but I suspect that the storm has abated - a line of stock gone through in round numbers?
jimmyloser
17/10/2018
15:46
Perhaps a wiff that the birch phase 3 has not gone well or just fustration that it wont be long before they have the cap out again looking for more cash....
elsa7878
17/10/2018
13:48
Well I've just taken a modest amount at 18p, just north of 3 year lows so watching with interest if we get a bounce... if not I've a fairly generous stop loss so may sell or double up if the fall continues unabated imo dyor ofc.
rathean
17/10/2018
13:07
No doubt guys, the phone line will be red hot right now to Worthing. Especially from those who have just bought in the oversubscribed fund raising at 27p? It looks to me as if we are in "This time next year" scenario again! I remain calm. dyor/impo
jimmyloser
17/10/2018
11:05
So why the continued share price drop? The update was solid if unexciting with big news on the horizon...
rathean
16/10/2018
07:49
Video now available for Nick Wykeman's presentation at the recent Shares Magazine Investor evening (good Q&A session at the end): https://www.sharesmagazine.co.uk/video/nick-wykeman-fd-allergy-therapeutics-agy-2
timbo003
11/10/2018
12:11
The markets are being hammered especially life science shares. Some of my other holdings EAH for example) have taken a much bigger hit. Painful but a correction has been a long time coming
audigger
11/10/2018
11:04
Jimmyloser....you're right, just letting off steam. Having held the shares for over 10 years I have developed some immunity to AGY's ups and downs. As with others on this board, I believe they have already proven their short term treatment works in Europe, don't need further capital injections and have significant upside if the Phase III trials are successful Essentially it's awaiting game. It still bugs me, however, how far this share can move on very little volume. Probably is a good time to top up.
mobox1
11/10/2018
10:08
Mobox This is AGY...relax. It is hurricane season.
jimmyloser
11/10/2018
09:46
This is either an amazing buying opportunity or there is something they are not telling us.
mobox1
Chat Pages: 145  144  143  142  141  140  139  138  137  136  135  134  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181024 05:11:22